Published 2023 | Version v1

Integrated proteomics and metabolomics analysis reveals new insight into the synergistic antitumor effect of valproic acid plus simvastatin in prostate cancer xenograft models associated with downmodulation of YPA/TAZ signaling

  • 1. ROR icon Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Description

Combined proteomic and metabolomic/lipidomic approach with the aim to characterize the molecular mechanism of valproic acid (VPA)/simvastatin (SIM) combination in tissue tumor samples derived from 22Rv1 mCRPC cells xenografted mice, with respect to untreated samples.

Files

proteomics raw data sample CTR_1___data_20231113_F001386_dat_rf_reportbuilder.csv